Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Envestnet Asset Management significantly raised its holdings in Amgen, reflecting growing confidence in the biotech giant.

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

Amgen Inc. closed 13.40% below its 52-week high of $346.85, which the company achieved on July 25th.

Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

From Amgen's classic double-bottom base in February 1990 until it ultimately topped in the summer of 2000, it increased more ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

The US biosimilar market expands with new denosumab options, enhancing treatment for patients with osteoporosis and ...

The Association of Black Cardiologists (ABC), a national 501c3 nonprofit focused on advancing cardiovascular wellness for all ...